Publications

Included here is a list of publications from OCG programs. All published data are available to the research community through the program-specific data matrices.

* denotes publications from the CTD2 initiative that are results of intra-Network collaborations

 

CTD²
April 01, 2021

Targeting BET proteins BRD2 and BRD3 in combination with PI3K-AKT inhibition as a therapeutic strategy for ovarian clear cell carcinoma

Molecular Cancer Therapeutics
Read more >
CTD²
March 11, 2021

DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia

Genome Research
Read more >
CTD²
March 04, 2021

An expanded universe of cancer targets*

Cell
Read more >
CTD²
March 01, 2021

YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell-Inflamed Phenotype

Journal of Thoracic Oncology
Read more >
CTD²
February 15, 2021

MEK inhibition remodels the immune landscape of mutant KRAS tumors to overcome resistance to PARP and immune checkpoint inhibitors

Cancer Research
Read more >
CTD²
February 03, 2021

Predicting cell health phenotypes using image-based morphology profiling

Molecular Biology of the Cell
Read more >
CTD²
February 01, 2021

Hormonal modulation of ESR1 mutant metastasis

Oncogene
Read more >
CTD²
February 01, 2021

Oncoprotein-specific molecular interaction maps (SigMaps) for cancer network analyses

Nature Biotechnology
Read more >
CTD²
January 28, 2021

Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers

JCO Precision Oncology
Read more >
CTD²
January 21, 2021

A modular master regulator landscape controls cancer transcriptional identity

Cell
Read more >

Pages

* denotes publications from the CTD2 initiative that are results of intra-Network collaborations

Last Updated: April 14, 2021

Content on this page maintained by the Office of Cancer Genomics

CSVXML